back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2026-06-15 16:03 Tx date 2026-06-15 |
$NPTH
NeuPath Health Inc. |
Chicoine, Daniel
4 - Director of Issuer
Direct Ownership
|
Common Shares
36 - Conversion or exchange
|
$12,600
+20,000 vol $0.63 each |
676,840 | |
| Filed 2026-06-15 16:02 Tx date 2026-06-15 |
$NPTH
NeuPath Health Inc. |
Chicoine, Daniel
4 - Director of Issuer
Direct Ownership
|
Restricted Share Unit (RSU)
36 - Conversion or exchange
|
-20,000 vol |
50,000 | |
| Filed 2026-06-15 16:00 Tx date 2026-06-11 |
$NPTH
NeuPath Health Inc. |
Chicoine, Daniel
4 - Director of Issuer
Direct Ownership
|
Restricted Share Unit (RSU)
30 - Acquisition or disposition under a purchase/ownership plan
|
+50,000 vol |
70,000 | |
| Filed 2026-06-09 00:00 Tx date 2024-05-06 |
$CTX
Crescita Therapeutics Inc. |
Chicoine, Daniel
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
-59,158 vol |
632,000 | |
| Filed 2026-06-09 00:00 Tx date 2026-06-03 |
$CTX
Crescita Therapeutics Inc. |
Chicoine, Daniel
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition
|
$-505,600
-632,000 vol $0.80 each |
0 | |
| Filed 2026-06-08 23:58 Tx date 2026-06-03 |
$CTX
Crescita Therapeutics Inc. |
Chicoine, Daniel
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Deferred Share Units (DSU)
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition
|
$-76,218.40
-95,273 vol $0.80 each |
0 | |
| Filed 2026-06-08 23:26 Tx date 2026-06-03 |
$CTX
Crescita Therapeutics Inc. |
Chicoine, Daniel
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Spousal TFSA (Indirect Ownership)
|
Common Shares
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition
|
$-99,903.20
-124,879 vol $0.80 each |
0 | |
| Filed 2026-06-08 23:25 Tx date 2026-06-03 |
$CTX
Crescita Therapeutics Inc. |
Chicoine, Daniel
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Spousal RRSP (Indirect Ownership)
|
Common Shares
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition
|
$-9,520
-11,900 vol $0.80 each |
0 | |
| Filed 2026-06-08 23:12 Tx date 2026-06-03 |
$CTX
Crescita Therapeutics Inc. |
Chicoine, Daniel
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: RRSP (Indirect Ownership)
|
Common Shares
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition
|
$-92,981.60
-116,227 vol $0.80 each |
0 | |
| Filed 2026-06-08 23:10 Tx date 2026-06-03 |
$CTX
Crescita Therapeutics Inc. |
Chicoine, Daniel
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Spousal Joint Account (Indirect Ownership)
|
Common Shares
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition
|
$-31,036
-38,795 vol $0.80 each |
0 | |
| Filed 2026-06-08 23:01 Tx date 2026-06-03 |
$CTX
Crescita Therapeutics Inc. |
Chicoine, Daniel
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: TFSA (Indirect Ownership)
|
Common Shares
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition
|
$-95,661.60
-119,577 vol $0.80 each |
0 | |
| Filed 2026-06-08 22:58 Tx date 2026-06-03 |
$CTX
Crescita Therapeutics Inc. |
Chicoine, Daniel
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition
|
$-516,799.20
-645,999 vol $0.80 each |
0 | |
| Filed 2026-05-25 16:07 Tx date 2026-05-22 |
$NPTH
NeuPath Health Inc. |
Chicoine, Daniel
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$126,000
+225,000 vol $0.56 each |
656,840 | |
| Filed 2026-05-22 10:39 Tx date 2026-05-21 |
$NPTH
NeuPath Health Inc. |
Chicoine, Daniel
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$56,999
+100,000 vol $0.57 each |
431,840 | |
| Filed 2026-05-22 10:38 Tx date 2026-05-21 |
$NPTH
NeuPath Health Inc. |
Chicoine, Daniel
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$41,160
+73,500 vol $0.56 each |
331,840 | |
| Filed 2025-12-18 11:23 Tx date 2025-12-16 |
$NPTH
NeuPath Health Inc. |
Chicoine, Daniel
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$8,800
+20,000 vol $0.44 each |
258,340 | |
| Filed 2025-12-18 11:22 Tx date 2025-12-16 |
$NPTH
NeuPath Health Inc. |
Chicoine, Daniel
4 - Director of Issuer
Direct Ownership
|
Restricted Share Unit (RSU)
57 - Exercise of rights
|
-20,000 vol |
20,000 | |
| Filed 2025-11-27 14:43 Tx date 2025-11-26 |
$NPTH
NeuPath Health Inc. |
Chicoine, Daniel
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$49,000
+140,000 vol $0.35 each |
238,340 | |
| Filed 2025-10-18 11:21 Tx date 2025-04-25 |
$NPTH
NeuPath Health Inc. |
Chicoine, Daniel
4 - Director of Issuer
Direct Ownership
|
Debentures
38 - Redemption, retraction, cancellation, repurchase
|
$
-$20,000 vol $1,030 each |
$0 | |
| Filed 2025-07-02 20:39 Tx date 2025-06-27 |
$CTX
Crescita Therapeutics Inc. |
Chicoine, Daniel
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Deferred Share Units (DSU)
56 - Grant of rights
|
$11,750
+23,980 vol $0.49 each |
95,273 |